Xanthene Pharma Private Limited
About Xanthene Pharma Private Limited
Data last updated:
Xanthene Pharma Private Limited is a private limited company based in Palakkad, Kerala, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 20 February 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U24233KL2009PTC023857.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rajeev Pazhedath (Managing Director) and Thichempully Sugunan Gopakumar.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at 195/5 Deepa Near Sai Samithi Puthur, Palakkad, Kerala, India – 678001.
As per the financials filed for FY 2019, the company reported a revenue of ₹30.78 Lakh, a decline of 53% compared to the previous year. For the same year it recorded a net loss of ₹12.54 Lakh (net margin -40.8%) and EBITDA of -₹12.55 Lakh (EBITDA margin -40.8%). Revenue has declined at a compounded annual rate (CAGR) of 30% over three years and 18% over five years.
As per MCA filings, the company has open charges of ₹12 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Xanthene Pharma Private Limited's registered office is in Palakkad, Kerala.
- Registered Address195/5 Deepa Near Sai Samithi Puthur, Palakkad, Kerala, India – 678001
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Xanthene Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Xanthene Pharma Private Limited, buy the company report.
Financials of Xanthene Pharma Private Limited
FY 2019 filings availableXanthene Pharma Private Limited reported revenue of ₹30.78 Lakh (down 53% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 18% over five years, including a 53% fall in the latest year. EBITDA fell 538% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹12.55 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹12.54 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -40.8% | ||||
| Net Profit Margin | -40.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Xanthene Pharma Private Limited, buy the company report.
Board of directors of Xanthene Pharma Private Limited
Xanthene Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Thichempully Sugunan Gopakumar | Director | 20 Feb 2009 | 17 Years 8 Months | Current |
| Rajeev Pazhedath | Managing Director | 20 Feb 2009 | 17 Years 8 Months | Current |
Peer comparison
Xanthene Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Phagoo Pharma Private Limited | ₹30.86 Lakh (FY 2025) | 21.0% | New Delhi, Delhi, India | |||
| Ehs Integration Private Limited | ₹30.82 Lakh (FY 2025) | -53.0% | Ballabgarh, Haryana, India | |||
| Taral Chemicals Private Limited | ₹30.81 Lakh (FY 2018) | 4283.0% | Ghaziabad, Uttar Pradesh, India | |||
| Satej Medinnova Private Limited | ₹30.8 Lakh (FY 2023) | Pune, Maharashtra, India | ||||
| MSB Health Care Private Limited | ₹30.79 Lakh (FY 2024) | -5.0% | Patna, Bihar, India | |||
| Xanthene Pharma Private Limitedthis company | ₹30.78 Lakh (FY 2019) | -₹12.54 Lakh | -40.8% | -53.0% | Palakkad, Kerala, India | |
| Ambimate Utility Private Limited | ₹30.78 Lakh (FY 2025) | 1.0% | Surat, Gujarat, India | |||
| Fervid Healthcare Private Limited | ₹30.77 Lakh (FY 2025) | 3.0% | Lucknow, Uttar Pradesh, India | |||
| Allied Polychem Private Limited | ₹30.73 Lakh (FY 2025) | 66.0% | Delhi, India | |||
| Brixy Pharmaceuticals Private Limited | ₹30.72 Lakh (FY 2019) | Hyderabad, Telangana, India | ||||
| Kasiraja Herbal Garden Private Limited | ₹30.71 Lakh (FY 2025) | 34.0% | Tamil Nadu, India |
To see the full peer comparison of Xanthene Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Oct 2009 | 10188855 | State Bank of Travancore | ₹12 Lakh | Open |
To see the full charge records of Xanthene Pharma Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Xanthene Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Xanthene Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Xanthene Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Xanthene Pharma Private Limited has 3 board changes on record since 2009: 2 appointments and 1 cessation. The latest: Edayal Kakkara Krishnan ceased to be Director on 04 Jun 2018.
Frequently asked questions
Xanthene Pharma is an active private limited company based in Palakkad, Kerala, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 20 February 2009 (17+ years old) and is registered under CIN U24233KL2009PTC023857.
Xanthene Pharma has 2 current directors:
- Rajeev Pazhedath - Managing Director
- Thichempully Sugunan Gopakumar - Director
The latest financial statements of Xanthene Pharma on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Xanthene Pharma is U24233KL2009PTC023857. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Xanthene Pharma was incorporated on 20 February 2009, making it 17+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of Xanthene Pharma by revenue are Phagoo Pharma Private Limited, Ehs Integration Private Limited, Taral Chemicals Private Limited, Satej Medinnova Private Limited, MSB Health Care Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Edayal Kakkara Krishnan ceased to be Director on 04 Jun 2018. Rajeev Pazhedath was appointed as Managing Director on 20 Feb 2009. Thichempully Sugunan Gopakumar was appointed as Director on 20 Feb 2009.
The registered office of Xanthene Pharma is at 1955 Deepa Near Sai Samithi Puthur, Palakkad, Kerala, India – 678001.
Xanthene Pharma operates in the chemicals industry, in the manufacturing segment.
Xanthene Pharma has open charges of ₹12 Lakh and no satisfied charges on record as per latest MCA filings.
The compliance status of Xanthene Pharma is compliant as of 01 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
